Ajanta Pharma Ltd

NSE :AJANTPHARM   BSE :532331  Sector : Pharmaceuticals
Buy, Sell or Hold AJANTPHARM? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

21 Nov
2945.50
(0.39%)
19 Nov
2933.95
(1.56%)
18 Nov
2888.95
(1.02%)
14 Nov
2859.85
(1.24%)
13 Nov
2824.90
(-0.46%)
12 Nov
2838.05
(-0.67%)
11 Nov
2857.30
(-0.24%)
08 Nov
2864.20
(-4.07%)
07 Nov
2985.60
(-4.18%)
06 Nov
3115.90
(0.13%)
05 Nov
3111.70
(4.26%)
04 Nov
2984.50
(-3.29%)
01 Nov
3086.15
(0.70%)
31 Oct
3064.70
(2.27%)
30 Oct
2996.65
(2.47%)
29 Oct
2924.35
(0.06%)
28 Oct
2922.60
(-1.57%)
25 Oct
2969.30
(-0.06%)
24 Oct
2970.95
(0.83%)
23 Oct
2946.40
(-1.04%)
22 Oct
2977.40
(-5.19%)


Technical Analysis

Short Term Investors

Bearish

Medium Term Investors

Very Bearish

Long Term Investors

Bullish

Moving Averages

5 DMA
Bullish

2895.83


10 DMA
Bullish

2914.53


20 DMA
Bearish

2956.72


50 DMA
Bearish

3137.24


100 DMA
Bullish

2927.18


200 DMA
Bullish

2582.39



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 21, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 3036.95 3001.4 2962.96 - -
R2 3001.4 2977.14 2957.14 3003.3 -
R1 2973.45 2962.16 2951.32 2977.25 2987.43
P 2937.9 2937.9 2937.9 2939.8 2944.89
S1 2909.95 2913.64 2939.68 2913.75 2923.93
S2 2874.4 2898.66 2933.86 2876.3 -
S3 2846.45 2874.4 2928.04 - -

Key Metrics

EPS

68.36

P/E

43.16

P/B

10.44

Dividend Yield

1.75%

Market Cap

36,793 Cr.

Face Value

2

Book Value

282.56

ROE

23.47%

EBITDA Growth

329.65 Cr.

Debt/Equity

0.01

Shareholding Pattern

  66.26% Total Promoter Holding
14.93% Mutual Fund Holdings
9.11% FIIs
7.52% Non Institution
1.57% Insurance Companies
0% Custodians
0.61% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Ajanta Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 1049.77 1118.74 1089.58 1171.39 1206.12
PROFIT 195.3 210.03 202.72 245.77 216.48
EPS 15.51 16.68 16.1 19.54 17.27

Ajanta Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 997.34 1099.02 959.75 1105.64 1169.25
PROFIT 212.36 220.15 162.69 236.03 234.98
EPS 16.87 17.48 12.92 18.77 18.75

Profit & Loss (Figures in Rs. Crores)


Ajanta Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1483.02 1819.79 2017.74 2199.14 2133.06 2696.81 3066.57 3539.84 3815.52 4332.52
PROFIT 314.81 416.7 509.77 468.65 387.14 470.53 651.29 713.28 594.01 808.03
EPS 22.94 31.33 38.2 35.32 29.41 35.55 50.13 55.34 46.54 64.6

Ajanta Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1380.68 1701.48 1863.99 1947.51 1942.15 2371.6 2896.76 3336.97 3566.01 4109.77
PROFIT 310.37 423.05 502.84 427.53 391.94 444.02 672.73 720.48 545.85 796.13
EPS 22.67 31.8 37.67 32.22 29.78 33.53 51.8 55.9 44.22 63.89

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 25.2725.2717.1717.3917.5417.5417.6917.6917.6917.68
Reserves Total 3,542.093,362.723,247.172,978.242,581.332,227.672,023.681,5501,173.17823.41
Total Shareholders Funds3,567.363,387.993,264.342,995.632,598.872,245.212,041.371,567.691,190.86841.09
Secured Loans 1.491.431.911.6945.6835.961.81.2859.6361.61
Unsecured Loans 33.7934.223.1229.6729.2800021.7210.77
Total Debt35.2835.6325.0331.3674.9635.961.81.2881.3572.38
Other Liabilities43.2527.8323.4122.5219.7813.7713.164.973.057.26
Total Liabilities3,645.893,451.453,312.783,049.512,693.612,294.942,056.331,573.941,275.26920.73
APPLICATION OF FUNDS :
Gross Block 2,389.412,282.822,217.792,140.781,976.151,593.351,417.23879.01715.73549.85
Less: Accumulated Depreciation910.22786.38705.8599.67504.01415.12364.57289.84264.99261.76
Net Block1,479.191,496.441,511.991,541.111,472.141,178.231,052.66589.17450.74288.09
Capital Work in Progress256.45209.47152.86108.19131.86261.6161.33339.26239.8170.2
Investments 348.63535.37146.96175.6779.4277.73189.96181.5686.0459.5
Inventories 828.36815.63791.07766.47495.68435.71350.63211.02204.58159.03
Sundry Debtors 1,246.841,056.91,019.81738.43775.3459.48459.79323.15372.35258.76
Cash and Bank Balance130.77330.9211.79209.61205.25100.5193.0969.9543.37136.76
Loans and Advances 194.9120.3119.93137.4198.34119.37137.7364.9266.1959.4
Total Current Assets2,400.872,323.732,142.61,851.921,574.571,115.071,041.24669.04686.49613.95
Current Liabilities 821.471,082.76622.18576.41523.06334.67312.79224.27182.06146.16
Provisions 62.5347.0918.7560.6320.867.6732.4722.1511.3564.3
Total Current Liabilities & Provisions8841,129.85640.93637.04543.92342.34345.26246.42193.41210.46
Net Current Assets1,516.871,193.881,501.671,214.881,030.65772.73695.98422.62493.08403.49
Deferred Tax Assets169.45131.0780.5760.2635.5662.8843.6136.4718.811.68
Deferred Tax Liability143.5132.02126.89102.3391.3289.976839.3629.5216.84
Net Deferred Tax25.95-0.95-46.32-42.07-55.76-27.09-24.39-2.89-10.71-15.16
Other Assets18.817.2445.6251.7335.331.7380.7944.2216.3114.61
Total Assets3,645.893,451.453,312.783,049.512,693.612,294.942,056.331,573.941,275.26920.73
Contingent Liabilities10.044.557.2882.950.1346.1211.6813.8320.266.24
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 25.2725.2717.1717.3917.5417.5417.6917.6917.6917.68
Reserves Total 3,388.33,221.183,152.012,867.592,443.762,124.541,913.811,486.251,114.01768.65
Total Shareholders Funds3,413.573,246.453,169.182,884.982,461.32,142.081,931.51,503.941,131.7786.33
Secured Loans 0000000058.1360.08
Unsecured Loans 30.5232.920.4925.9123.490009.9510.78
Total Debt30.5232.920.4925.9123.4900068.0870.86
Other Liabilities43.2527.8323.4122.5219.7813.7713.164.983.047.26
Total Liabilities3,487.343,307.183,213.082,933.412,504.572,155.851,944.661,508.921,202.82864.45
APPLICATION OF FUNDS :
Gross Block 2,355.332,246.282,163.182,086.541,926.651,555.611,379.38843.35679.21510.92
Less : Accumulated Depreciation 890.44762.27670.86567.75477.33393.59342.69270.42246.38239.6
Net Block 1,464.891,484.011,492.321,518.791,449.321,162.021,036.69572.93432.83271.32
Capital Work in Progress256.45209.47152.86108.19131.06261.2961.33339.26239.8170.2
Investments 367.14553.26164.85156.8885.7783200.64198.8294.0376.62
Inventories 677.79683.77635.11634.22436.19414.26317.37179.28189.78153.05
Sundry Debtors 1,207.67977.631,043.62782.3734.24423.38432.19336350.48240.85
Cash and Bank Balance63.06269.92145.25151.9887.8535.8738.6722.8421.44105.69
Loans and Advances 163.1109.6111.17128.7289.66110.21124.455.3959.9453.98
Total Current Assets2,111.622,040.921,935.151,697.221,347.94983.72912.63593.51621.64553.57
Current Liabilities 566.54874.39446.8459.91444.53299.09279.48191.4175.93141.94
Provisions 55.0625.518.7446.5718.897.6720.7120.8411.3664.3
Total Current Liabilities & Provisions621.6899.89465.54506.48463.42306.76300.19212.24187.29206.24
Net Current Assets1,490.021,141.031,469.611,190.74884.52676.96612.44381.27434.35347.33
Deferred Tax Assets3534.328.150002111.985.821.68
Deferred Tax Liability143.5132.02130.0292.1781.1658.96839.3629.416.84
Net Deferred Tax-108.5-97.72-101.87-92.17-81.16-58.9-47-27.38-23.58-15.16
Other Assets17.3417.1335.3150.9835.0631.4880.5644.0225.3914.14
Total Assets3,487.343,307.183,213.082,933.412,504.572,155.851,944.661,508.921,202.82864.45
Contingent Liabilities10.044.557.2882.950.1346.1211.7713.9120.356.46

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...1,113.93
Depreciation135.4
Interest (Net)7.21
P/L on Sales of Assets-3.49
P/L in Forex-9.42
Others-389.19
Total Adjustments (PBT and Ext...83.03
Operating Profit before Workin...1,196.96
Trade and 0ther Receivables-178.88
Inventories-12.3
Trade Payables40.85
Loans and Advances-16.57
Total Adjustments (OP before W...-99.76
Cash Generated from/(used in) ...1,097.2
Direct Taxes Paid-312.13
Total Adjustments(Cash Generat...-312.13
Cash Flow before Extraordinary...785.07
Net Cash from Operating Activi...785.07
Sale of Fixed Assets13.38
Purchase of Investments-2,079.76
Sale of Investments2,257.39
Net Cash used in Investing Act...65.39
Proceed from 0ther Long Term B...0.06
Of Financial Liabilities-16.23
Dividend Paid-642.17
Interest Paid-3.53
Net Cash used in Financing Act...-1,051.06
Net Profit before Tax and Extr...1,096.95
Depreciation132.16
Interest (Net)6.8
Dividend Received29.13
P/L on Sales of Assets-3.49
P/L in Forex-9.42
Others-389.2
Total Adjustments (PBT and Ext...49.31
Operating Profit before Workin...1,146.26
Trade and 0ther Receivables-221.02
Inventories5.98
Trade Payables30.86
Loans and Advances1.61
Total Adjustments (OP before W...-158.63
Cash Generated from/(used in) ...987.63
Direct Taxes Paid-252.28
Total Adjustments(Cash Generat...-252.28
Cash Flow before Extraordinary...735.35
Net Cash from Operating Activi...735.35
Sale of Fixed Assets12.18
Purchase of Investments-2,079.76
Sale of Investments2,257.39
Interest Received38.21
Net Cash used in Investing Act...105.02
Of Financial Liabilities-12.91
Dividend Paid-642.17
Interest Paid-3.42
Net Cash used in Financing Act...-1,047.7

Company Details

Registered Office
AddressAjanta House,
Charkop Kandivli (W)
CityMumbai
StateMaharashtra
Pin Code400067
Tel. No.91-22-66061000/1204/1203
Fax. No.91-22-66061200/1300
Emailinfo@ajantapharma.com; investorgrievance@ajantapha
Internethttp://www.ajantapharma.com
Registrars
AddressAjanta House
CityMumbai
StateMaharashtra
Pin Code400067
Tel. No.91-22-66061000/1204/1203
Fax. No.91-22-66061200/1300
Emailinfo@ajantapharma.com; investorgrievance@ajantapha
Internethttp://www.ajantapharma.com
Management
Name Designation
Mannalal B AgrawalChairman (Non-Executive)
Madhusudan B AgrawalVice Chairman
Yogesh AgrawalManaging Director
Chandrakanth M KhetanIndependent Director
Gaurang ShahVice President & CS
Rajesh M AgrawalJoint Managing Director
K H ViswanathanIndependent Director
Prabhakar DalalIndependent Director
Anjana GrewalIndependent Director
David RasquinhaIndependent Director
Medha JoshiIndependent Director
Simi ThaparIndependent Director
Rajesh Shashikant DalalIndependent Director